XML 24 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated statements of cash flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities      
Profit for the year [1] $ 81,999 $ 87,045 $ 103,984
Adjustments to reconcile profit for the year to net cash provided by operating activities:      
Activities of derivative financial instruments used for hedging (26,363) 21,333 (2,279)
Depreciation of equipment and leasehold improvements 1,578 1,457 1,371
Amortization of intangible assets 838 629 596
Loss for disposal of equipment and leasehold improvements 2,205 140 32
Loss for disposal of intangible assets 16 0 1
Impairment loss from expected credit losses [1] 9,439 35,115 18,090
Net (gain) loss on sale of financial assets at fair value through OCI (249) 356 (363)
Compensation cost - share-based payment 296 3,063 3,296
Interest income (226,079) (245,898) (220,312)
Interest expense 106,264 90,689 74,833
Net decrease (increase) in operating assets:      
Net decrease (increase) in pledged deposits 8,571 (29,148) 6,546
Financial instruments at fair value through profit or loss 0 53,411 2,545
Net decrease (increase) in loans at amortized cost 479,226 650,217 (7,410)
Other assets (269) (39) (7,738)
Net increase (decrease) in operating liabilities:      
Net increase due to depositors 125,992 7,383 288,775
Financial liabilities at fair value through profit or loss (24) (65) 37
Other liabilities (4,695) (1,774) 6,398
Cash provided by operating activities 558,745 673,914 268,402
Interest received 239,394 247,167 223,033
Interest paid (107,051) (91,802) (71,972)
Net cash provided by operating activities 691,088 829,279 419,463
Cash flows from investing activities:      
Acquisition of equipment and leasehold improvements (2,654) (3,973) (615)
Acquisition of intangible assets (3,370) (3,111) 0
Proceeds from the redemption of of financial instruments at fair value through OCI 0 107,088 151,131
Proceeds from the sale of financial instruments at fair value through OCI 17,040 102,655 118,210
Proceeds from maturities of financial instruments at amortized cost 18,258 55,240 44,923
Purchases of financial instruments at fair value through OCI (8,402) (84,153) (86,629)
Purchases of financial instruments at amortized cost (9,978) (24,600) (96,920)
Net cash provided by investing activities 10,894 149,146 130,100
Cash flows from financing activities:      
Net decrease in short-term borrowings and debt and securities sold under repurchase agreements (397,352) (1,074,366) (448,615)
Proceeds from long-term borrowings and debt 219,905 403,489 946,084
Repayments of long-term borrowings and debt (857,799) (508,564) (462,559)
Dividends paid (60,605) (60,135) (59,943)
Exercised stock options 4,977 1,575 1,467
Repurchase of common stock (27) 0 0
Net cash used in financing activities (1,090,901) (1,238,001) (23,566)
Net (decrease) increase in cash and cash equivalents (388,919) (259,576) 525,997
Cash and cash equivalents at beginning of the year 1,007,726 1,267,302 741,305
Cash and cash equivalents at end of the year $ 618,807 $ 1,007,726 $ 1,267,302
[1] The numbers set out in these tables have been rounded and accordingly may not total exactly.